Infographic: Consensus Recommendations on Biosimilars in Rheumatology

October 8, 2017
The Center for Biosimilars Staff

An international panel of healthcare stakeholders recently released consensus recommendations for the use of biosimilars to treat rheumatologic diseases. Learn more about what the panel had to say.

An international panel of healthcare stakeholders recently released consensus recommendations for the use of biosimilars to treat rheumatologic diseases. Learn more about what the panel had to say.

Related Content:

News | Practice | Business | Policy